CVE-2018-14786: Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are…

PriorityP263critical9.4CVSS 3.0

AVNACLPRNUINSUCLIHAH

EPSS

3.06%

85.9th percentile

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Affected

4 ranges

Vendor	Product	Version range	Fixed in
bd	alaris_cc_firmware	<= 2.3.6	—
bd	alaris_gh_firmware	<= 2.3.6	—
bd	alaris_gs_firmware	<= 2.3.6	—
bd	alaris_tiva_firmware	<= 2.3.6	—

CVSS provenance

nvdv3.09.4CRITICALCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H

nvdv2.07.5HIGHAV:N/AC:L/Au:N/C:P/I:P/A:P

Stop checking back — get the weekly exploitation signal.

Every Monday: what got weaponized or added to CISA KEV in the last seven days — each CVE cross-linked to its PoC, Nuclei template, and detection rule. Free, one email a week, unsubscribe in one click.